OnKure Therapeutics, Inc.

NasdaqGM:OKUR Stock Report

Market Cap: US$39.8m

OnKure Therapeutics Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

NasdaqGM:OKUR Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
07 Apr 25SellUS$9,178Jason LeveroneIndividual3,122US$3.33
07 Apr 25SellUS$2,570Nicholas SaccomanoIndividual874US$3.33

Insider Trading Volume

Insider Buying: OKUR insiders have only sold shares in the past 3 months.

Ownership Breakdown

What is the ownership structure of OKUR?
Owner TypeNumber of SharesOwnership Percentage
Individual Insiders2,311,50915.3%
Hedge Funds2,912,05319.2%
VC/PE Firms3,268,26821.6%
Institutions6,636,31543.9%

Dilution of Shares: OKUR only recently listed within the past 12 months

Top Shareholders

Top 25 shareholders own 104.58% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
13.8%
Anthony Piscopio
1,848,409US$5.5m0%no data
13.7%
Cormorant Asset Management, LP
1,837,739US$5.4m0%0.51%
10.7%
Acorn Bioventures
1,439,674US$4.3m0%4.06%
8%
Citadel Advisors LLC
1,074,314US$3.2m0%no data
7.48%
Perceptive Advisors LLC
1,004,439US$3.0m0%0.12%
6.13%
Samsara BioCapital LLC
824,155US$2.4m0%0.52%
5.26%
The Vanguard Group, Inc.
706,733US$2.1m0%no data
4.73%
Vestal Point Capital, LP
635,000US$1.9m0%0.15%
3.9%
Deep Track Capital, LP
523,989US$1.6m0%0.08%
3.66%
StepStone Group Inc.
491,938US$1.5m0%1.61%
3.56%
New Enterprise Associates, Inc.
478,548US$1.4m0%0.1%
2.98%
Highbridge Capital Management, LLC
399,743US$1.2m0%0.17%
2.57%
BML Capital Management, LLC
345,739US$1.0m0%0.77%
2.19%
Tang Capital Management, LLC
294,626US$872.1k0%0.07%
2.01%
Abingworth LLP
269,895US$798.9k0%0.71%
1.89%
Ikarian Capital, LLC
253,754US$751.1k0%0.34%
1.86%
Bank of America Corporation, Asset Management Arm
249,642US$738.9k0%no data
1.67%
Octagon Capital Advisors LP
225,000US$666.0k0%0.17%
1.63%
Altium Capital Management LP
218,386US$646.4k0%0.3%
1.51%
Lundbeckfonden BioCapital
203,122US$601.2k0%0.01%
1.46%
RiverVest Venture Management LLC
196,198US$580.7k0%29.77%
1.07%
Affinity Asset Advisors, LLC
144,159US$426.7k0%0.11%
1.07%
Millennium Management LLC
144,099US$426.5k0%no data
0.93%
James Winkler
124,642US$368.9k0%no data
0.87%
James Blake
117,488US$347.8k0%no data

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/04/11 16:46
End of Day Share Price 2025/04/11 00:00
Earnings2024/12/31
Annual Earnings2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

OnKure Therapeutics, Inc. is covered by 4 analysts. 4 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Robert BurnsH.C. Wainwright & Co.
Soumit RoyJonesTrading Institutional Services, LLC
Andrew BerensLeerink Partners LLC